FR / EN
Portfolio
VCIC is currently in a phase of active investment in Canada, leveraging an existing portfolios of in France of CM-CIC Capital Finance cumulating over 600 companies.
VCIC has positioned itself as a true partner, showing real interest in the company, beyond simply the return on their investment, and this was very important for us during this first round of financing. Its investment model backed by their own equity resources is reassuring and testifies to their commitment to long-term support. What's more, VCIC's French roots enable us to anticipate an easier European development in the medium term. 
Richard Philippe, President and CEO of Logi-D
Activities overview
The company offers its clients (healthcare establishments) a turnkey hospital supply chain management solution. This solution, which integrates leading edge technology like RFID and voice recognition, enables an approximately 30% reduction in medical supplies stocks, a 50% reduction in waste, and even a 50% increase in productivity (healthcare workers' time is freed for the benefit of the patient).
The partnership between VCIC and TrioMed Innovations has proven to be very beneficial both from the financial and strategic standpoints. The resulting synergy will enable effective European introduction of our products.
Jean-Pierre Messier, President and CEO of TrioMed Innovations
Activities overview
TrioMed Innovations is dedicated to the development of novel, antimicrobial technologies and high performance products that help prevent the spread of infections and disease such as respirators, wound dressing or surgical gloves. The market is of the order of $30 billion in the US alone. The technology developed by the company, Triosyn, is significantly more effective and less costly than the current industry standard, silver oxide. Triomed currently has several marketed and FDA-approved products.